342.00EUR+0.74%Mkt Cap: 2.93B EURP/E: 19.46Last update: 2026-05-14
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Paci…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)19.46
P/E (Forward)15.22
PEG3.27
P/B2.61
P/S2.00
EV/EBITDA11.12
EV/Revenue2.11
EPS (TTM)17.99
EPS (Forward)23.00
Cash Flow & Leverage
FCF Yield4.32%
FCF Margin8.65%
Operating CF198.99M EUR
CapEx (TTM)102.14M EUR
Net Debt/EBITDA0.59
Net Debt163.48M EUR
Technical
SMA 50356.33 (-4.0%)
SMA 200347.43 (-1.6%)
Beta0.77
S&P 52W Chg24.23%
Avg Vol (30d)3.81K
Avg Vol (10d)3.89K
Technical Indicators
RSI (14)36.6
MACD-3.6411
MACD Signal0.4789
MACD Hist.-4.1200
BB Upper393.22 EUR
BB Middle366.55 EUR
BB Lower339.88 EUR
BB Width14.55%
ATR (14)10.17 EUR
Vol Ratio (20d)1.67x
52W Range
296.0049% of range389.50
52W High389.50 EUR
52W Low296.00 EUR
Profitability
Gross Margin66.58%
EBITDA Margin19.00%
Profit Margin10.30%
Oper. Margin13.47%
ROE13.41%
ROA7.88%
Revenue Growth4.60%
Earnings Growth35.20%
Balance Sheet
Debt/Equity0.26
Current Ratio1.53
Quick Ratio0.77
Book Value/Sh134.31 EUR
Cash/Share15.06 EUR
Dividends
Fwd Div Rate1.450 EUR
Trail. Div Rate1.450 EUR
Div. Yield0.41%
5Y Avg Yield1.14%
Payout Ratio8.06%
Ex-Div DateJun 24, 2025
Pay Date—
Splits
Last Split4:1
Split DateJul 30, 2002
Ownership
Shares Out.8.38M
Float4.13M
Insiders50.82%
Institutions25.14%
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)413.00 EUR
Target Range368.00 EUR – 440.00 EUR
# Analysts9
Company
Market Cap2.93B EUR
Enterprise Value3.10B EUR
Revenue (TTM)1.46B EUR
Gross Profit975.17M EUR
Net Income (TTM)150.89M EUR
Revenue/Share174.85 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees6.4K
Last Price342.00 EUR
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFR0000031577